| ||
| Less Toxic Combination of Erlotinib And Bevacizumab Is Effective ... CHICAGO, IL (June 4, 2011)––The standard treatment for patients with advanced non-small cell lung cancer (NSCLC) is a combination of two old-fashioned ... www.sciencenewsline.com/medicine/2011060209170030.html |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment